109890-22-4

Upstream product

• 109890-21-3 [1-Amino-1-mercapto-meth-(Z)-ylidene]-methyl-[4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenyl]-ammonium; iodide 
• 107-15-3 ethylenediamine 
• 109890-19-9 N-<<<4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl>amino>thiooxomethyl>benzamide 
• 87693-29-6 N-<4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl>thiourea 

Relevant academic research and scientific papers

Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correl

The structure-activity relationships of a series of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds were investigated for the in vivo inhibition of different forms of cyclic nucleotide phosphodiesterase (PDE) isolated

6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds

6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds possessing strong platelet aggregation inhibiting activity and blood pressure depressing activity, having the general formula: STR1 wherein R1 is hydrogen or lower alkyl; R2/